4//SEC Filing
NISSEN TORBEN STRAIGHT 4
Accession 0001104659-19-020219
CIK 0001709401other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 7:34 PM ET
Size
6.7 KB
Accession
0001104659-19-020219
Insider Transaction Report
Form 4
NISSEN TORBEN STRAIGHT
President
Transactions
- Sale
Common Stock
2019-04-03$20.00/sh−500$10,000→ 1,859,500 total - Sale
Common Stock
2019-04-05$20.00/sh−12,096$241,920→ 1,847,404 total
Footnotes (2)
- [F1]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The Reporting Person undertakes to provide to Rubius Therapeutics, Inc., any security holder of Rubius Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Rubius Therapeutics, Inc.
CIK 0001709401
Entity typeother
Related Parties
1- filerCIK 0001746647
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 7:34 PM ET
- Size
- 6.7 KB